PUBLICATIONS · 23414589
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2013 Mar
- First author
- Haddad R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2013 Mar;14(3):188-9. doi: 10.1016/S1470-2045(13)70023-8.
- note
- Source null
- related pmid
- 23414586
- relationship
- Comment in
- citation
- Strahlenther Onkol. 2013 Sep;189(9):809-10. doi: 10.1007/s00066-013-0420-4.
- note
- Source null
- related pmid
- 23907138
- relationship
- Comment in
Authors and identifiers
- name
- Haddad R
- type
- Author
- name
- O'Neill A
- type
- Author
- name
- Rabinowits G
- type
- Author
- name
- Tishler R
- type
- Author
- name
- Khuri F
- type
- Author
- name
- Adkins D
- type
- Author
- name
- Clark J
- type
- Author
- name
- Sarlis N
- type
- Author
- name
- Lorch J
- type
- Author
- name
- Beitler JJ
- type
- Author
- name
- Limaye S
- type
- Author
- name
- Riley S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Haddad R
- type
- Author
- name
- O'Neill A
- type
- Author
- name
- Rabinowits G
- type
- Author
- name
- Tishler R
- type
- Author
- name
- Khuri F
- type
- Author
- name
- Adkins D
- type
- Author
- name
- Clark J
- type
- Author
- name
- Sarlis N
- type
- Author
- name
- Lorch J
- type
- Author
- name
- Beitler JJ
- type
- Author
- name
- Limaye S
- type
- Author
- name
- Riley S
- type
- Author
- bibliography ids
- nci-bib-7c1a049522dc630f7ff59ad4
- book metadata
- content sha256
- dc198c1e3d7ab3a2e54968cd96b4bc8f784280841dff393ad26a73bcd0a68302
- document type
- citation
- dois
- 10.1016/S1470-2045(13)70011-1
- electronic publication date
- display
- 2013 Feb 13
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23414589
- immutable id
- pubmed:23414589@dc198c1e3d7ab3a2e54968cd96b4bc8f784280841dff393ad26a73bcd0a68302
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 3
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 257-64
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2013 Mar;14(3):188-9. doi: 10.1016/S1470-2045(13)70023-8.
- note
- Source null
- related pmid
- 23414586
- relationship
- Comment in
- citation
- Strahlenther Onkol. 2013 Sep;189(9):809-10. doi: 10.1007/s00066-013-0420-4.
- note
- Source null
- related pmid
- 23907138
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 23414589
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- 2822e27983281067819d26cfe1e1456fbd2c80e8796ae9ad5ff28acfbfd1f098
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Mar
- precision
- month
- year
- 2013
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Preserved source evidence · Not medical advice
Triangle